Clinical Trial: Vilazodone for Separation Anxiety Disorder

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Vilazodone for Separation Anxiety Disorder

Brief Summary: The purpose of this study is to determine whether Vilazodone (Viibryd), an SSRI and 5HT1a receptor agonist, is effective in treating Adult Separation Anxiety Disorder over a 12-week treatment course.